Role of novel biomarkers of inflammation in patients with stable coronary heart disease

Angiology

Volumn 58, Issue 2, 2007, Pages 148-155

  Oren, Hüseyin ^a,c   Erbay, Ali R ^a   Balci, Mustafa ^a   Çehreli, Sengül ^b  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^b INONU UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; COLONY STIMULATING FACTOR 1; INTERLEUKIN 3;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; MACROPHAGE; MALE; NEPHELOMETRY;

ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; CORONARY DISEASE; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-3; LINEAR MODELS; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES;

EID: 34247622463     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319707300349     Document Type: Article

References (35)

1. Libby P., Ridker PM, Maseri A.: Inflammation and atherosclerosis. Circulation 105: 1135-1143, 2002.
2. Kohchi K., Takebayashi S., Hiroki T.,, et al. Significance of adventitial inflammation of the coronary artery in patients with unstable angina: Results at autopsy. Circulation 4: 709-716, 1985.
3. Pockley AG: Heat shock proteins, inflammation and cardiovascular disease. Circulation 105: 1012-1017, 2002.
4. Young JL, Libby P., Schönbeck U.: Cytokines in the pathogenesis of atherosclerosis. Thromb Haemost 88: 554-567, 2002.
5. Ridker PM: Evaluating novel cardiovascular risk factors: Can we better predict heart attacks? Ann Intern Med 130: 933-937, 1999.
6. Tracy RP: Atherosclerosis, thrombosis and inflammation: A problem of linkage. Fibrinolysis Proteolysis 11 (suppl 1). 137-141, 1997.
7. Lagrand W.K., Visser CA, Hermens W.T.,, et al. C-reactive protein as a cardiovascular risk factor: More than an epiphenomenon? Circulation 100: 96-102, 1999.
8. Liuzzo G., Biasucci LM, Gallimore R.,, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 331: 417-420, 1994.
9. Tashiro H., Simokawa H., Yamamoto K.,, et al. Altered plasma levels of cytokines in patients with ischaemic heart disease. Coron Artery Dis 8: 143-147, 1997.
10. Tashiro H., Simokawa H., Yamamoto K.,, et al. Monocyte-related cytokines in acute myocardial infarction. Am Heart J 130: 446-452, 1995.
11. Libby P., Ridker PM: Novel inflammatory markers of coronary risk: Theory versus practice. Circulation 100: 1148-1150, 1999.
12. Tracy RP, Psaty BM, Macy E.,, et al. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vasc Biol 17: 2167-2176, 1997.
13. Hoffmeister A., Rothenbacher D., Bazner U.,, et al. Role of novel markers of inflammation in patients with stable coronary heart disease. Am J Cardiol 87: 262-266, 2001.
14. Danesh J., W hincup P., W alker M.,, et al. Low-grade inflammation and coronary heart disease: Prospective study and updated meta-analysis. Br Med J 321: 199-204, 2000.
15. Tataru MC, Heinrich J., Junker R.,, et al. C-reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris. Eur Heart J 21: 1000-1008, 2000.
16. Madsen T., Skou HA, Hansen VE,, et al. C-reactive protein, dietary n-3 fatty acids, and the extent of coronary artery disease. Am J Cardiol 88: 1139-1142, 2001.
17. Redberg RF, Rifai N., Gee L.,, et al. Lack of association of C-reactive protein and coronary calcium by electron beam computed tomography in postmenopausal women: Implications for coronary artery disease screening. J Am Coll Cardiol 36: 39-43, 2000.
18. Hunt ME, O'Malley PG, Vernalis MN,, et al. C-reactive protein is not associated with the presence or extent of calcified subclinical atherosclerosis. Am Heart J 141: 206-210, 2001.
19. Pasceri V., W illerson Jt, Yeh ET: Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102: 2165-2168, 2000.
20. Du Clos TW: Function of C-reactive protein. Ann Med 32: 274-278, 2000.
21. Pearson TA, Mensah GA, Alexander RW,, et al. AHA/ CDC Scientific Statement. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice. Circulation 107: 499-511, 2003.
22. Ikonomidis I., Andreotti F., Economou E.,, et al. Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation 100: 793-798, 1999.
23. Rosenfeld ME, Yla-Herttuala S., Lipton BA,, et al. Macrophage colony-stimulating factor mRNA and protein in atherosclerotic lesions of rabbits and humans. Am J Pathol 140: 291-300, 1992.
24. Shyy J., W ickham Ll Hagan JP,, et al. Human monocyte colony-stimulating factor stimulates gene expression of monocyte chemotactic protein 1 and increases the adhesion of monocytes to endothelial monolayers. J Clin Invest 92: 1745-1751, 1993.
25. Tilg H., Mair J., Herold M., et al: Acute phase response after myocardial infarction: Correlation between serum levels of cytokines and C-reactive protein. Klin W ochenschr 68: 1083, 1990.
26. Clark SC, Kamen R.: The human hemopoietic growth factors. Science (Wash DC) 236: 1229-1237, 1987.
27. Wimperis JZ, Niemeyer CM, Sieff CA,, et al. Granulocyte-macrophage colony-stimulating factor and interleukin-3 mRNA are produced by a small fraction of blood mononuclear cells. Blood 74: 1525-1530, 1989.
28. W odnar-Filipowicz A., Heusser CH, Moroni C.: Production of the hemopoietic growth factors GM-CSF and IL-3 by mast cell in response to Ig E receptor-mediated activation. Nature 339: 150-152, 1989.
29. Razin E., Leslie K., Schrader JW: Connective tissue mast cells in contact with fibroblasts express IL-3 mRNA. Analysis of single cells by polymerase chain reaction. J Immunol 146: 981-987, 1991.
30. Brizzi MF, Garbarino G., Rossi PR,, et al. Interleukin 3 stimulates proliferation and triggers endothelial-leukocyte adhesion molecule 1 gene activation of human endothelial cells. J Clin Invest 91: 2887-2892, 1993.
31. Khew-Goodall Y., Butcher M., Litwin MS,, et al. Chronic expression of P-selectin on endothelial cells stimulated by the T-cell cytokine, interleukine-3. Blood 87: 1432-1438, 1996.
32. Frostegard J., Ulfgren AK, Nyberg P.,, et al. Cytokine expression in advanced human atherosclerotic plaques: Dominance of pro-inflammatory (Th 1) and macrophage-stimulating cytokines. Atherosclerosis 45: 33-43, 1999.
33. Brizzi MF, Formato L., Dentelli P.,, et al. Interleukine-3 stimulates migration and proliferation of vascular smooth muscle cells: A potential role in atherogenesis? Circulation 103: 549-554, 2001.
34. Saitoh T., Kishida H., Tsukada Y.,, et al. Clinical significance of increased plasma concentration of macrophage colony-stimulating factor in patients with angina pectoris. J Am Coll Cardiol 35: 655-665, 2000.
35. Ridker PM, Rifai N., Pfeffer MA,, et al. Long-term effects of pravastatin on plasma concentration of C-reactive protein. The CARE investigators. Circulation 100: 230-235, 1999.